tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Roy Buchanan, 73 are a BUY (97.33%), 2 are a HOLD (2.67%).
Analyst Roy Buchanan, currently employed at JMP, carries an average stock price target met ratio of 33.13% that have a potential upside of 31.34% achieved within 102 days.
Roy Buchanan’s has documented 147 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CDTX, Cidara Therapeutics at 02-Oct-2025.
Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for CDTX (CIDARA THERAPEUTICS) at 6/2/2025. The price target of $47 was fulfilled within 23 days with a profit of $24.33 (107.32%) receiving and performance score of 46.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5.5
$0.14 (2.61%)
$12
4 months 5 days ago
(25-Jun-2025)
1/3 (33.33%)
$0.1 (1.85%)
13
Buy
$10
$4.64 (86.57%)
$16
5 months 3 days ago
(27-May-2025)
0/9 (0%)
$5.56 (125.23%)
Hold
$3.9
$-1.46 (-27.24%)
$35
1 years 2 months 1 days ago
(29-Aug-2024)
2/2 (100%)
$0.76 (24.20%)
98
Sell
$8
$2.64 (49.25%)
$20
2 years 2 months 10 days ago
(20-Aug-2023)
4/4 (100%)
$-0.89 (-10.01%)
32
Hold
$21
$15.64 (291.79%)
$58
2 years 9 months 22 days ago
(08-Jan-2023)
1/2 (50%)
$10.64 (102.70%)
63
Which stock is Roy Buchanan is most bullish on?
Which stock is Roy Buchanan is most reserved on?
What Year was the first public recommendation made by Roy Buchanan?
